Psoriasis Treatments

New Data Shows LEO Pharma A/S Investigational Psoriasis Treatment, Enstilar … – PR Newswire (press release)

New Data Shows LEO Pharma A/S Investigational Psoriasis Treatment, Enstilar …PR Newswire (press release)LEO Pharma A/S today announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam EnstilarĀ® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g), the Company's dual-action investigational …and more »

[monetize id=”1″]
[monetize id=”2″]

http://www.dpsw.org